ArticleFrontiers in pharmacology2025

Gut microbiota-derived metabolite phenylacetylglutamine inhibits the progression of prostate cancer by suppressing the Wnt/β-catenin signaling pathway.

Jing Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.